111 related articles for article (PubMed ID: 32661325)
1. Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.
Toda J; Ichii M; Oritani K; Shibayama H; Tanimura A; Saito H; Yokota T; Motooka D; Okuzaki D; Kitai Y; Muromoto R; Kashiwakura JI; Matsuda T; Hosen N; Kanakura Y
Oncogene; 2020 Aug; 39(34):5601-5615. PubMed ID: 32661325
[TBL] [Abstract][Full Text] [Related]
2. Spred1 deficit promotes treatment resistance and transformation of chronic phase CML.
Qiao J; Liang C; Zhao D; Nguyen LXT; Chen F; Suo S; Hoang DH; Pellicano F; Rodriguez IR; Elhajmoussa Y; Ghoda L; Yoshimura A; Stein AS; Ali H; Koller P; Perrotti D; Copland M; Han A; Zhang BA; Marcucci G
Leukemia; 2022 Feb; 36(2):492-506. PubMed ID: 34564700
[TBL] [Abstract][Full Text] [Related]
3. A KLF4-DYRK2-mediated pathway regulating self-renewal in CML stem cells.
Park CS; Lewis AH; Chen TJ; Bridges CS; Shen Y; Suppipat K; Puppi M; Tomolonis JA; Pang PD; Mistretta TA; Ma L; Green MR; Rau R; Lacorazza HD
Blood; 2019 Nov; 134(22):1960-1972. PubMed ID: 31515251
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of the
Zeng J; Liang X; Duan L; Tan F; Chen L; Qu J; Li J; Li K; Luo D; Hu Z
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):525-537. PubMed ID: 38414349
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo.
LaMontagne KR; Flint AJ; Franza BR; Pandergast AM; Tonks NK
Mol Cell Biol; 1998 May; 18(5):2965-75. PubMed ID: 9566916
[TBL] [Abstract][Full Text] [Related]
6. TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling.
Agarwal P; Li H; Choi K; Hueneman K; He J; Welner RS; Starczynowski DT; Bhatia R
Cell Rep; 2021 Jul; 36(2):109386. PubMed ID: 34260914
[TBL] [Abstract][Full Text] [Related]
7. Targeting quiescent leukemic stem cells using second generation autophagy inhibitors.
Baquero P; Dawson A; Mukhopadhyay A; Kuntz EM; Mitchell R; Olivares O; Ianniciello A; Scott MT; Dunn K; Nicastri MC; Winkler JD; Michie AM; Ryan KM; Halsey C; Gottlieb E; Keaney EP; Murphy LO; Amaravadi RK; Holyoake TL; Helgason GV
Leukemia; 2019 Apr; 33(4):981-994. PubMed ID: 30185934
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells.
Agarwal P; Isringhausen S; Li H; Paterson AJ; He J; Gomariz Á; Nagasawa T; Nombela-Arrieta C; Bhatia R
Cell Stem Cell; 2019 May; 24(5):769-784.e6. PubMed ID: 30905620
[TBL] [Abstract][Full Text] [Related]
9. Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1-independent disease progression.
Cerny-Reiterer S; Ghanim V; Hoermann G; Aichberger KJ; Herrmann H; Muellauer L; Repa A; Sillaber C; Walls AF; Mayerhofer M; Valent P
Neoplasia; 2012 Jul; 14(7):572-84. PubMed ID: 22904675
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 regulates metabolism and leukemogenic potential in CML stem cells.
Abraham A; Qiu S; Chacko BK; Li H; Paterson A; He J; Agarwal P; Shah M; Welner R; Darley-Usmar VM; Bhatia R
J Clin Invest; 2019 Jun; 129(7):2685-2701. PubMed ID: 31180336
[TBL] [Abstract][Full Text] [Related]
11. Impaired immunomodulatory function of chronic myeloid leukemia cancer stem cells and the possible mechanism involved in it.
Xishan Z; Xinna Z; Baoxin H; Jun R
Cancer Immunol Immunother; 2013 Apr; 62(4):689-703. PubMed ID: 23180012
[TBL] [Abstract][Full Text] [Related]
12.
Pellicano F; Park L; Hopcroft LEM; Shah MM; Jackson L; Scott MT; Clarke CJ; Sinclair A; Abraham SA; Hair A; Helgason GV; Aspinall-O'Dea M; Bhatia R; Leone G; Kranc KR; Whetton AD; Holyoake TL
Blood; 2018 Apr; 131(14):1532-1544. PubMed ID: 29437554
[TBL] [Abstract][Full Text] [Related]
13. The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemia.
Zheng R; Wei W; Liu S; Zeng D; Yang Z; Tang J; Tan J; Huang Z; Gao M
Cell Commun Signal; 2024 Jun; 22(1):314. PubMed ID: 38849885
[TBL] [Abstract][Full Text] [Related]
14. ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis.
Zipeto MA; Court AC; Sadarangani A; Delos Santos NP; Balaian L; Chun HJ; Pineda G; Morris SR; Mason CN; Geron I; Barrett C; Goff DJ; Wall R; Pellecchia M; Minden M; Frazer KA; Marra MA; Crews LA; Jiang Q; Jamieson CHM
Cell Stem Cell; 2016 Aug; 19(2):177-191. PubMed ID: 27292188
[TBL] [Abstract][Full Text] [Related]
15. Zinc as a potential regulator of the BCR-ABL oncogene in chronic myelocytic leukemia cells.
Zhu B; Sun L; Li Z; Shang P; Yang C; Li K; Li J; Zhi Q; Hua Z
J Trace Elem Med Biol; 2024 May; 83():127407. PubMed ID: 38325182
[TBL] [Abstract][Full Text] [Related]
16. Potential role of Wnt/β-catenin signaling in blastic transformation of chronic myeloid leukemia: cross talk between β-catenin and BCR-ABL.
Hu J; Feng M; Liu ZL; Liu Y; Huang ZL; Li H; Feng WL
Tumour Biol; 2016 Nov; ():. PubMed ID: 27817074
[TBL] [Abstract][Full Text] [Related]
17. LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells.
Höpner SS; Raykova A; Radpour R; Amrein MA; Koller D; Baerlocher GM; Riether C; Ochsenbein AF
Nat Commun; 2021 Feb; 12(1):1065. PubMed ID: 33594067
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway.
Dai Z; Quackenbush RC; Courtney KD; Grove M; Cortez D; Reuther GW; Pendergast AM
Genes Dev; 1998 May; 12(10):1415-24. PubMed ID: 9585502
[TBL] [Abstract][Full Text] [Related]
19. Platelet microparticles influence gene expression and modulate biological activities of chronic myeloid leukemia cells (K562).
Nikravesh F; Mirzaee Khalilabadi R; Farsinejad A; Mardani Valandani H
Mol Biol Rep; 2024 May; 51(1):676. PubMed ID: 38796661
[TBL] [Abstract][Full Text] [Related]
20. CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML.
Guo C; Lv X; Zhang Q; Yi L; Ren Y; Li Z; Yan J; Zheng S; Sun MZ; Liu S
J Cell Mol Med; 2024 May; 28(9):e18308. PubMed ID: 38683131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
